Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors (Q36904551)
Jump to navigation
Jump to search
scientific article published on March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors |
scientific article published on March 2013 |
Statements
Local therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitors (English)
Helena A Yu
Stephen B Solomon
Andreas Rimner
Paul Paik
M Catherine Pietanza
Christopher G Azzoli
Naiyer A Rizvi
Lee M Krug
Vincent A Miller
Gregory J Riely
1 March 2013
1 reference
1 reference
1 reference
1 reference